Literature DB >> 3092924

Markers of HTLV-III in patients with end stage renal failure.

R S Rodger, J S Tapson, A A Codd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3092924      PMCID： PMC1341343          DOI： 10.1136/bmj.293.6546.565

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

Authors:  M Goldman; C Liesnard; J L Vanherweghem; N Dolle; C Toussaint; S Sprecher; J Cogniaux; L Thiry
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-19

2.  HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

Authors:  P Kühnl; S Seidl; G Holzberger
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

3.  HTLV-III in symptom-free seronegative persons.

Authors:  S Z Salahuddin; J E Groopman; P D Markham; M G Sarngadharan; R R Redfield; M F McLane; M Essex; A Sliski; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321
  3 in total
  1 in total

1.  HIV testing in patients with end stage renal disease.

Authors:  A Stevens; J Little; S Kerr; P Kilbane; C Doherty
Journal:  BMJ       Date:  1990-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.